Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • France open to sending fighter jets to Ukraine
    • ‘Hybrid identities’: why Germany is updating its citizenship rules
    • Eurozone avoids recession as economy expands in fourth quarter
    • US says Russia is not complying with New Start nuclear arms treaty
    • US and India launch ambitious tech and defence initiatives
  • UK
    Sections
    • UK Home
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • Is the IMF right about the UK economy?
    • UK companies fail at fastest rate since financial crisis
    • ‘Unique’ Tudor pendant unearthed by UK metal detecting enthusiast
    • Rishi Sunak faces crunch decision on post-Brexit Northern Ireland
    • Simon Case: can the head of Britain’s civil service survive?
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Boeing delivers last 747, a jumbo jet that ‘shrank the world’
    • Gautam Adani pulls off $2.4bn share sale despite short-seller report
    • Perella Weinberg banker tied to insider trading probe found dead
    • Universal Music in talks with big platforms to overhaul streaming model
    • Goldman Sachs transferred privately held Russian assets to former employees
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Gautam Adani pulls off $2.4bn share sale despite short-seller report
    • Live news updates from January 31: Eurozone economy grows in Q4, ExxonMobil posts record profit
    • Perella Weinberg banker tied to insider trading probe found dead
    • Live news: Shares in Adani companies tumble
    • ‘Colossal’ central bank buying drives gold demand to decade high
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Conservatives are too keen on money to win the culture war
    • When good economic news may not be good news
    • The real cost of shadow work
    • The kids are alright after all
    • Finland prepares to go solo if Turkey stymies Sweden’s Nato bid
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Shoshana Zuboff: ‘Privacy has been extinguished. It is now a zombie’
    • A new generation refuses to keep quiet on age discrimination at work
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Why I’m only buying five new things in 2023
    • Episode 3 of ‘The Last of Us’ shows TV at its best
    • Top tech for the perfect bedroom ambience
    • Beyond the Light, Metropolitan Museum review — how Danish painters forged a unique national style
    • The secrets of the Holy Halls
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Disease control and prevention

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Sunday, 29 January, 2023
    Drugs research
    RQ Bio partners with AstraZeneca in Covid antibody fight

    UK biotech racing to keep antibody up to date with latest variants

  • Thursday, 26 January, 2023
    UK universities
    Lack of clinical academics threatens NHS research and teaching, say peers

    Shortage of doctors with university posts is putting health service on ‘dangerous precipice’

  • Tuesday, 24 January, 2023
    Kate Bingham
    Britain is losing its chance to become a life sciences superpower

    Short-termism and suspicion in parts of government risk our valuable future in precision medicine

  • Monday, 23 January, 2023
    News in-depthCoronavirus treatment
    Rural China runs short of Covid drugs over lunar new year holiday

    Officials row with Pfizer over price as villages struggle to obtain antiviral medication

  • Tuesday, 17 January, 2023
    InterviewJenny Harries
    Covid will ‘taunt us’ for years, says UK health security chief

    Future of pandemic less predictable than at the outset because of new variants, says Jenny Harries

  • Sunday, 15 January, 2023
    Coronavirus pandemic
    WHO calls on China to release more data on Covid outbreak

    Beijing reports almost 60,000 deaths in month since abandoning pandemic restrictions

  • Friday, 13 January, 2023
    Wes Streeting
    Only radical thinking can find a long-term cure for the NHS

    Starting with primary care, investment combined with modernisation can deliver better outcomes for patients

  • Thursday, 12 January, 2023
    EU economy
    EU draws up plans to stockpile scarce medicines

    Effort to improve health supply chain issues that have led to Greece imposing an export ban on drugs

  • Wednesday, 11 January, 2023
    Anjana Ahuja
    New Alzheimer’s drug straddles uneasy gulf between help and harm

    For all its landmark status, lecanemab may end up representing a triumph of hope over evidence

  • Tuesday, 10 January, 2023
    BioNTech
    BioNTech buys UK AI start-up InstaDeep in £562mn deal

    Covid vaccine maker looks to use machine learning to help discover new treatments

  • Tuesday, 10 January, 2023
    Covid-19 vaccines
    Chinese bank tries to entice wealthy customers with mRNA vaccines

    Hong Kong-based lender seeks to cater to mainlanders’ demand for western jabs

  • Tuesday, 10 January, 2023
    Coronavirus pandemic
    China suspends travel visas from Japan and S Korea over Covid curbs

    Beijing accuses countries of ‘political manipulation’ for introducing testing requirements during exit wave

  • Tuesday, 10 January, 2023
    Coronavirus pandemic
    China’s Covid patients face medical debt crisis as insurers refuse coverage

    Narrow definition of cases leaves claimants on the hook after state-backed policies drop free care

  • Monday, 9 January, 2023
    Disrupted Times
    World awaits return of Chinese tourists

    Also in this edition: eurozone unemployment falls to new low, uproar in Brazil and Rolls-Royce hits sales record

  • Monday, 9 January, 2023
    CureVac GmbH
    Covid vaccine makers CureVac and Novavax appoint new chiefs

    Pharmaceutical groups to part ways with longstanding executives

  • Monday, 9 January, 2023
    InterviewPharmaceuticals sector
    SK Bioscience says ‘national pride’ prevents China from accepting foreign Covid jabs

    South Korean vaccine maker looks elsewhere to expand overseas business

  • Sunday, 8 January, 2023
    Medical science
    Alphabet’s Verily seeks to eradicate dengue in Singapore

    Bid to extend tech throughout city state to wipe out disease-carrying mosquito population

  • Friday, 6 January, 2023
    Pharmaceuticals sector
    US approves Alzheimer’s drug that slows rate of cognitive decline

    High price of treatment and restrictions on medicine developed by Eisai and Biogen will limit patient access initially

  • Friday, 6 January, 2023
    Covid-19 vaccines
    New Chinese mRNA Covid vaccine shows positive early results

    Jab developed by CanSinoBio could help nation grappling with a wave of infection

  • Friday, 6 January, 2023
    Coronavirus economic impact
    Ambulances left waiting for record times as ‘twindemic’ hits UK

    Covid and flu hospitalisations soar over Christmas as emergency service delays worsen

  • Friday, 6 January, 2023
    News in-depthDrugs research
    A pharma partnership that brought a breakthrough in breast cancer

    Daiichi Sankyo and AstraZeneca’s Enhertu could double time patients can live without their condition progressing

  • Friday, 6 January, 2023
    Medical science
    UK signs deal with BioNTech for cutting-edge cancer trials

    Covid-19 vaccine maker hails ‘huge’ investment aimed at recruiting 10,000 participants with NHS

  • Thursday, 5 January, 2023
    OutlookPatti Waldmeir
    The surprising Covid legacy for America’s homeschoolers

    While most children are back to the old routine, 3.7mn US households are still teaching their kids at home

  • Thursday, 5 January, 2023
    ExplainerCoronavirus pandemic
    How serious is the threat of new Covid-19 variants?

    A surge in cases after China lifted restrictions has sparked concerns that a dangerous new strain could emerge

  • Thursday, 5 January, 2023
    The Big Read
    The UK’s dream of becoming a ‘science superpower’

    Ministers want to supercharge the £89bn life science industry. But it will take long-term thinking on investment, talent and infrastructure

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In